1-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperidine hydrochloride

Catalog No. :
ACECJI162
CAS No. :
135-87-5
Molecular Formula :
C14H20ClNO2
Molecular Weight :
269.77

IUPAC Name:1-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperidine hydrochloride

1-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg99%$108.00Login to see priceIn stockInquiry
100mg99%$183.00Login to see priceIn stockInquiry
250mg99%$348.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperidine hydrochloride
IUPAC Name1-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperidine hydrochloride
Molecular FormulaC14H20ClNO2
Molecular Weight269.77
SMILES[H]Cl.N1(CC2COC3=CC=CC=C3O2)CCCCC1
InChI KeyBITRJBQGQMGGQI-UHFFFAOYSA-N
SynonymFOURNEAU-933 HYDROCHLORIDE | Fourneau 933 hydrochloride | Piperoxanhydrochloride | Benzodioxane hydrochloride | SCHEMBL12503311 | AC-36835 | F85476 | Piperoxane hydrochloride | AKOS032944971 | CS-6070 | KBio1_000338 | 1-(1,4-Benzodioxan-2-ylmethyl)piperid
CAS No.135-87-5
PubChem CID101619

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACECJI162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACECJI162 route product structure diagram
    ACECJI162135-87-5 In Stock
Inquiry

2. ACECJI162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACECJI162 route product structure diagram
    ACECJI162135-87-5 In Stock
Inquiry

Comments (0)